Understanding RAC

Inspired by this post I have six points for discussion. Choose one of them and start discussing.

1. High probability of success - significance of the historic trials in terms of probability of success of Pillars 2 and 3 ( Breast Cancer and AML trials )
2. The baseline value of Pillars 2 and 3 to Big Pharma (in the context of probability shown by #1)
3. The potential stratospheric value of Pillar 1 to Big Pharma (lots of great info has been shared by @Mason14 in this post)
4. That Big Pharma initiate most buyout transactions during Preclinical, Phase 1 or 2
5. That RACE is significantly undervalued to peers in the US
6. The effort that management are putting into getting this right